Citigroup’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.52M Buy
456,621
+257,560
+129% +$3.68M ﹤0.01% 1246
2025
Q1
$2.09M Sell
199,061
-85,055
-30% -$893K ﹤0.01% 2052
2024
Q4
$3.44M Buy
284,116
+48,074
+20% +$582K ﹤0.01% 1721
2024
Q3
$3.47M Sell
236,042
-334,081
-59% -$4.91M ﹤0.01% 1609
2024
Q2
$8.23M Buy
570,123
+424,744
+292% +$6.13M 0.01% 966
2024
Q1
$2.37M Buy
145,379
+21,931
+18% +$357K ﹤0.01% 1720
2023
Q4
$1.84M Buy
123,448
+31,228
+34% +$465K ﹤0.01% 1706
2023
Q3
$1.04M Sell
92,220
-132,612
-59% -$1.49M ﹤0.01% 1882
2023
Q2
$2.26M Sell
224,832
-317,886
-59% -$3.2M ﹤0.01% 1585
2023
Q1
$5.1M Buy
542,718
+322,953
+147% +$3.04M ﹤0.01% 1115
2022
Q4
$2.69M Sell
219,765
-214,021
-49% -$2.62M ﹤0.01% 1340
2022
Q3
$5.38M Sell
433,786
-38,218
-8% -$474K ﹤0.01% 1090
2022
Q2
$9.27M Sell
472,004
-1,451,750
-75% -$28.5M 0.01% 860
2022
Q1
$50.2M Buy
1,923,754
+320,895
+20% +$8.37M 0.03% 343
2021
Q4
$45.5M Buy
1,602,859
+84,485
+6% +$2.4M 0.02% 389
2021
Q3
$48.4M Buy
1,518,374
+225,142
+17% +$7.18M 0.03% 380
2021
Q2
$44.9M Buy
1,293,232
+56,071
+5% +$1.95M 0.03% 421
2021
Q1
$36.4M Buy
1,237,161
+411,158
+50% +$12.1M 0.02% 479
2020
Q4
$25.3M Buy
826,003
+445,990
+117% +$13.7M 0.02% 576
2020
Q3
$10.6M Buy
380,013
+253,144
+200% +$7.07M 0.01% 821
2020
Q2
$2.72M Sell
126,869
-14,911
-11% -$320K ﹤0.01% 1406
2020
Q1
$3.17M Buy
141,780
+20,853
+17% +$467K ﹤0.01% 1155
2019
Q4
$3.56M Buy
120,927
+16,835
+16% +$496K ﹤0.01% 1294
2019
Q3
$2.77M Sell
104,092
-3,687
-3% -$98K ﹤0.01% 1394
2019
Q2
$3.64M Sell
107,779
-1,472,400
-93% -$49.8M ﹤0.01% 1265
2019
Q1
$50.7M Buy
1,580,179
+1,574,790
+29,222% +$50.5M 0.05% 222
2018
Q4
$169K Buy
5,389
+1,187
+28% +$37.2K ﹤0.01% 3202
2018
Q3
$147K Buy
+4,202
New +$147K ﹤0.01% 3338